224 related articles for article (PubMed ID: 36162872)
21. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
[TBL] [Abstract][Full Text] [Related]
22. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.
Chan ED; Kaminska AM; Gill W; Chmura K; Feldman NE; Bai X; Floyd CM; Fulton KE; Huitt GA; Strand MJ; Iseman MD; Shapiro L
Scand J Infect Dis; 2007; 39(8):690-6. PubMed ID: 17654345
[TBL] [Abstract][Full Text] [Related]
23. Alpha-1-antitrypsin inhibits nitric oxide production.
Chan ED; Pott GB; Silkoff PE; Ralston AH; Bryan CL; Shapiro L
J Leukoc Biol; 2012 Dec; 92(6):1251-60. PubMed ID: 22975343
[TBL] [Abstract][Full Text] [Related]
24. Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.
Zhu H; He J; Liu J; Zhang X; Yang F; Liu P; Wang S
Exp Biol Med (Maywood); 2018 Jan; 243(1):87-95. PubMed ID: 29096562
[TBL] [Abstract][Full Text] [Related]
25. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
Mordwinkin NM; Louie SG
Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
[TBL] [Abstract][Full Text] [Related]
26. Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro?
Persson C; Subramaniyam D; Stevens T; Janciauskiene S
Chest; 2006 Jun; 129(6):1683-92. PubMed ID: 16778290
[TBL] [Abstract][Full Text] [Related]
27. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy.
Brigham KL; Lane KB; Meyrick B; Stecenko AA; Strack S; Cannon DR; Caudill M; Canonico AE
Hum Gene Ther; 2000 May; 11(7):1023-32. PubMed ID: 10811231
[TBL] [Abstract][Full Text] [Related]
28. Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.
Rosenberg JB; De BP; Greco A; Gorman N; Kooner V; Chen A; Yost-Bido M; Munoz-Zuluaga C; Kaminsky SM; Rostami M; Monette S; Crystal RG; Sondhi D
Hum Gene Ther; 2023 Feb; 34(3-4):139-149. PubMed ID: 36606685
[TBL] [Abstract][Full Text] [Related]
29. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
30. α1-antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells.
van 't Wout EF; van Schadewijk A; Savage ND; Stolk J; Hiemstra PS
Am J Respir Cell Mol Biol; 2012 May; 46(5):607-13. PubMed ID: 22162908
[TBL] [Abstract][Full Text] [Related]
31. α
Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
[TBL] [Abstract][Full Text] [Related]
32. A review of α1-antitrypsin deficiency.
Stoller JK; Aboussouan LS
Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema.
Takeda K; Kim SH; Joetham A; Petrache I; Gelfand EW
Respir Res; 2021 Jul; 22(1):207. PubMed ID: 34271910
[TBL] [Abstract][Full Text] [Related]
34. Role for Cela1 in Postnatal Lung Remodeling and Alpha-1 Antitrypsin-Deficient Emphysema.
Joshi R; Heinz A; Fan Q; Guo S; Monia B; Schmelzer CEH; Weiss AS; Batie M; Parameshwaran H; Varisco BM
Am J Respir Cell Mol Biol; 2018 Aug; 59(2):167-178. PubMed ID: 29420065
[TBL] [Abstract][Full Text] [Related]
35. Alpha1-antitrypsin protects lung cancer cells from staurosporine-induced apoptosis: the role of bacterial lipopolysaccharide.
Schwarz N; Tumpara S; Wrenger S; Ercetin E; Hamacher J; Welte T; Janciauskiene S
Sci Rep; 2020 Jun; 10(1):9563. PubMed ID: 32533048
[TBL] [Abstract][Full Text] [Related]
36. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
[TBL] [Abstract][Full Text] [Related]
37. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
[TBL] [Abstract][Full Text] [Related]
38. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro.
Aldonyte R; Jansson L; Janciauskiene S
BMC Cell Biol; 2004 Mar; 5():11. PubMed ID: 15050036
[TBL] [Abstract][Full Text] [Related]
39. α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts.
Nakagiri T; Wrenger S; Sivaraman K; Ius F; Goecke T; Zardo P; Grau V; Welte T; Haverich A; Knöfel AK; Janciauskiene S
Respir Res; 2021 Nov; 22(1):295. PubMed ID: 34789247
[TBL] [Abstract][Full Text] [Related]
40. Alpha-1-antitrypsin in cell and organ transplantation.
Berger M; Liu M; Uknis ME; Koulmanda M
Am J Transplant; 2018 Jul; 18(7):1589-1595. PubMed ID: 29607607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
